Citation: | FANG Jiangen, WANG Xuliang, LING Jingjing, YIN Wei, XU Jinyi, JI Hui, ZHANG Yihua. Synthesis and antiplatelet aggregation/antioxidant activity of 3-alkyl-benzo[c] selenophen-1(3H)-ones[J]. Journal of China Pharmaceutical University, 2015, 46(5): 552-555. DOI: 10.11665/j.issn.1000-5048.20150506 |
[1] |
William AS,Wang X,Pancras CW.New advances in treating thrombtic diseases[J].Drug Discov Today,2014,19(9):1433-1434.
|
[2] |
Leys D,Balucani C,Cordonnier C.Antiplatelet drugs for ischemic stroke prevention[J].Cerebrovasc Dis,2009,27:120-125.
|
[3] |
Yang CY,Huang ZJ,Ling JJ,et al.Synthesis and evaluation of carbamate-isosorbide-3-n-butylphthalide ring opening derivative trihybrids as novel platelet aggregation inhibitor[J].J China Pharm Univ(中国药科大学学报),2013,44(3):202-206.
|
[4] |
Zhang Y, Wang L, Li J, et al. 2-(1-Hydroxypentyl)-benzoate increases cerebral blood flow and reduces infarct volume in rats model of transient focal cerebral ischemia[J].J Pharmacol Exp Ther,2006,317(3):973-979.
|
[5] |
Zhu Y, Tan S. Observation of dl-3-n-butylphthalide combined edarovone treating 36 patients with progressive cerebral infarction[J].Chin J Pract Nerv Dis(中国实用神经疾病),2010,13:10-12.
|
[6] |
Wu J,Ling JJ,Wang XL,et al.Discovery of a potential anti-ischemic stroke agent:3-pentylbenzo[c]thiophen- 1(3H)one[J].J Med Chem,2012,55(16):7173-7181.
|
[7] |
Thomson CD.Assessment of requirements for selenium and adequacy of selenium status:a review[J].Eur J Clin Nutr,2004,58(3):391-402.
|
[1] | SHANG Feiyang, LIU Chengbo, TAN Hongzhou, HE Bing, HE Liqin. Design, synthesis and antiplatelet aggregation activity of 3-acetyl-7-hydroxycoumarin derivatives[J]. Journal of China Pharmaceutical University, 2024, 55(3): 367-374. DOI: 10.11665/j.issn.1000-5048.2023072901 |
[2] | DAI Weiguo, TAN Hongzhou, GU Hongxia, HE Bing, HE Liqin, HUANG Peng. Design, synthesis and anti-platelet aggregation activity of paeonol oxime derivatives[J]. Journal of China Pharmaceutical University, 2022, 53(5): 535-541. DOI: 10.11665/j.issn.1000-5048.20220504 |
[3] | WANG Xiaoli, WANG Zhaoya, WANG Linna, JI Hui, ZHANG Yihua, YIN Jian. Design, synthesis and evaluation of hydrogen sulfide-releasing derivatives of ring opening 3-n-butylphthalide as novel platelet aggregation inhibitors[J]. Journal of China Pharmaceutical University, 2016, 47(2): 158-162. DOI: 10.11665/j.issn.1000-5048.20160205 |
[4] | FANG Jiangen, WANG Xuliang, LING Jingjing, YIN Wei, XU Jinyi, JI Hui, ZHANG Yihua. Synthesis and antiplatelet aggregation/antioxidant activity of 3-alkyl-benzo[c] selenophen-1(3H)-ones[J]. Journal of China Pharmaceutical University, 2015, 46(5): 552-555. DOI: 10.11665/j.issn.1000-5048.20150506 |
[5] | WU Mingming, FANG Lei, GOU Shaohua, CHEN Li. 以2-甲基-2-取代苯氧基丙酸为离去基团的铂(Ⅱ)配合物的合成、表征及细胞毒活性[J]. Journal of China Pharmaceutical University, 2013, 44(4): 303-306. DOI: 10.11665/j.issn.1000-5048.20130403 |
[6] | YANG Chunyu, HUANG Zhangjian, LING Jingjing, JI Hui, LAI Yisheng, XU Jinyi, PENG Sixun, ZHANG Yihua. Synthesis and evaluation of carbamate-isosorbide-3-n-butylphthalide ring opening derivative trihybrids as novel platelet aggregation inhibitors[J]. Journal of China Pharmaceutical University, 2013, 44(3): 202-206. DOI: 10.11665/j.issn.1000-5048.20130302 |
[7] | ZHANG Bo-yu, SHAN Jia-qi, LIU Lin, JIAO Bo, SUN Hong-bin. Synthesis and antiplatelet aggregation activities of prasugrel derivatives[J]. Journal of China Pharmaceutical University, 2011, 42(4): 305-309. |
[8] | Synthesis and anti-platelet aggregation activity of substituted (E)-1,2-diarylethene compounds[J]. Journal of China Pharmaceutical University, 2010, 41(5): 419-423. |
[9] | LI Bao-quan, LI Nian-guang, FENG Feng, TANG Yu-ping, DUAN Jin-ao. Synthesis and anti-platelet aggregation activities of ferulic acid esters[J]. Journal of China Pharmaceutical University, 2009, 40(6): 486-490. |
[10] | Synthesis and Antiplatelet Aggregation of N Acylated Tetrahydrobenzylisoquinoline[J]. Journal of China Pharmaceutical University, 1997, (5): 3+6-7. |